Foreword |
|
xv | |
Acknowledgments |
|
xvii | |
|
I Cardiovascular Medicine |
|
|
|
|
1 | (4) |
|
|
|
5 | (5) |
|
|
3 Acute Coronary Syndrome |
|
|
10 | (4) |
|
|
4 Conduction Blocks and Bradyarrhythmias |
|
|
14 | (4) |
|
|
5 Supraventricular Arrhythmias |
|
|
18 | (4) |
|
|
6 Ventricular Arrhythmias |
|
|
22 | (4) |
|
|
|
26 | (4) |
|
|
|
30 | (5) |
|
|
II Endocrinology and Metabolism |
|
|
|
|
35 | (5) |
|
|
10 Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar Syndrome |
|
|
40 | (2) |
|
|
|
|
42 | (4) |
|
|
|
|
46 | (5) |
|
|
|
51 | (5) |
|
|
|
56 | (3) |
|
|
III Gastroenterology and Hepatology |
|
|
|
15 Approach to Abdominal Pain |
|
|
59 | (5) |
|
|
|
64 | (4) |
|
|
17 Approach to Liver Chemistry Tests |
|
|
68 | (2) |
|
|
18 Diseases of the Gallbladder and Bile Ducts |
|
|
70 | (3) |
|
|
|
73 | (3) |
|
|
20 Gastroesophageal Reflux Disease |
|
|
76 | (2) |
|
|
|
78 | (3) |
|
|
|
81 | (3) |
|
|
23 Approach to Gastrointestinal Bleeding |
|
|
84 | (4) |
|
|
|
88 | (4) |
|
|
|
92 | (4) |
|
|
26 Inflammatory Bowel Disease |
|
|
96 | (5) |
|
|
IV General Internal Medicine |
|
|
|
|
101 | (3) |
|
|
28 Health Promotion, Screening, and Prevention |
|
|
104 | (4) |
|
|
|
108 | (4) |
|
|
|
112 | (4) |
|
|
|
116 | (4) |
|
|
32 Approach to Low Back Pain |
|
|
120 | (3) |
|
|
|
123 | (4) |
|
|
|
127 | (3) |
|
|
|
130 | (3) |
|
|
36 Approach to Involuntary Weight Loss |
|
|
133 | (3) |
|
|
|
37 Disorders of Menstruation and Menopause |
|
|
136 | (5) |
|
|
38 Common Dermatologic Disorders |
|
|
141 | (6) |
|
|
39 Approach to Lymphadenopathy |
|
|
147 | (2) |
|
|
40 Comprehensive Geriatric Assessment |
|
|
149 | (5) |
|
|
|
|
154 | (5) |
|
|
|
|
|
159 | (7) |
|
|
|
166 | (4) |
|
|
|
170 | (3) |
|
|
|
173 | (3) |
|
|
|
176 | (3) |
|
|
|
179 | (4) |
|
|
|
183 | (4) |
|
|
VI Infectious Disease Medicine |
|
|
|
|
187 | (3) |
|
|
|
190 | (4) |
|
|
51 Common Upper Respiratory Problems |
|
|
194 | (3) |
|
|
52 Urinary Tract Infection |
|
|
197 | (3) |
|
|
53 Sexually Transmitted Diseases |
|
|
200 | (4) |
|
|
54 Human Immunodeficiency Virus Infection |
|
|
204 | (4) |
|
|
55 Health Care-Associated Infections |
|
|
208 | (4) |
|
|
|
212 | (4) |
|
|
57 Community-Acquired Pneumonia |
|
|
216 | (4) |
|
|
58 Infective Endocarditis |
|
|
220 | (3) |
|
|
|
223 | (4) |
|
|
|
|
60 Approach to Kidney Disease |
|
|
227 | (4) |
|
|
|
231 | (5) |
|
|
62 Chronic Kidney Disease |
|
|
236 | (5) |
|
|
|
241 | (4) |
|
|
64 Fluid and Electrolyte Disorders |
|
|
245 | (5) |
|
|
65 Calcium and Phosphorus Metabolism |
|
|
250 | (3) |
|
|
|
|
66 Approach to the Altered Mental State |
|
|
253 | (4) |
|
|
|
257 | (3) |
|
|
|
260 | (3) |
|
|
69 Approach to Selected Movement Disorders |
|
|
263 | (2) |
|
|
70 Approach to Meningitis and Encephalitis |
|
|
265 | (4) |
|
|
71 Stroke and Transient Ischemic Attack |
|
|
269 | (3) |
|
|
|
272 | (3) |
|
|
|
|
|
275 | (3) |
|
|
|
278 | (3) |
|
|
|
281 | (3) |
|
|
|
284 | (3) |
|
|
|
287 | (3) |
|
|
|
290 | (4) |
|
|
|
294 | (3) |
|
|
|
|
80 Interpretation of Pulmonary Function Tests |
|
|
297 | (3) |
|
|
|
300 | (4) |
|
|
|
304 | (4) |
|
|
|
308 | (4) |
|
|
84 Chronic Obstructive Pulmonary Disease |
|
|
312 | (4) |
|
|
85 Obstructive Sleep Apnea |
|
|
316 | (3) |
|
|
86 Infiltrative and Fibrotic Lung Diseases |
|
|
319 | (4) |
|
|
87 Venous Thromboembolism |
|
|
323 | (4) |
|
|
|
|
88 Approach to Joint Pain |
|
|
327 | (3) |
|
|
89 Approach to Knee and Shoulder Pain |
|
|
330 | (3) |
|
|
|
333 | (3) |
|
|
91 Crystal-Induced Arthritis |
|
|
336 | (3) |
|
|
|
339 | (3) |
|
|
|
342 | (4) |
|
|
|
|
346 | (3) |
|
|
95 Systemic Lupus Erythematosus |
|
|
349 | (3) |
|
|
|
96 Other Rheumatologic Conditions |
|
|
352 | (5) |
|
|
|
357 | (4) |
|
Index |
|
361 | |